Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of IDN-6556 in Cirrhotic Subjects With Portal Hypertension

ClinicalTrials.gov ID: NCT02230683

Public ClinicalTrials.gov record NCT02230683. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 9:07 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label Pilot Trial to Evaluate the Safety, Tolerability and Efficacy of IDN-6556 in Cirrhotic Subjects With Portal Hypertension

Study identification

NCT ID
NCT02230683
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Conatus Pharmaceuticals Inc.
Industry
Enrollment
23 participants

Conditions and interventions

Interventions

  • IDN-6556 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2014
Primary completion
Apr 30, 2015
Completion
May 31, 2015
Last update posted
Dec 20, 2016

2014 – 2015

United States locations

U.S. sites
16
U.S. states
11
U.S. cities
13
Facility City State ZIP Site status
VA Connecticut Healthcare System West Haven Connecticut 06516
Johns Hopkins Sibley Memorial Hospital Washington D.C. District of Columbia 20016
University of Miami Miami Florida 33136
Johns Hopkins Hospital Baltimore Maryland 21287
University of Mississippi Medical Center Jackson Mississippi 39216
Rutgers New Jersey Medical School Newark New Jersey 07103
North Shore University Hospital Manhasset New York 11030
New York University Lagone Medical Center New York New York 10016
University of Pennsylvania Philadelphia Pennsylvania 19104
Albert Einstein Medical Center Philadelphia Pennsylvania 19141
St. Luke's Health Baylor College of Medicine Houston Texas 77030
University of Texas Health Science Center at Houston Houston Texas 77030
University of Utah Hospital Salt Lake City Utah 84132
Bon Secours Mary Immaculate Hospital Newport News Virginia 23602
Bon Secours St. Mary's Hospital Richmond Virginia 23226
McGuire DVAMC Richmond Virginia 23249

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02230683, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 20, 2016 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT02230683 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →